The global Placental Growth Factors Market is poised for significant growth, with forecasts indicating an impressive surge from US$ 34.9 million in 2023 to over US$ 64.6 million by 2033, marking a robust CAGR of 6.3% during this ten-year span.
The Placental Growth Factors market revolves around therapeutic interventions and diagnostic procedures closely tied to the vital proteins known as placental growth factors. These proteins play a pivotal role in the growth and function of the placenta during pregnancy. They promote angiogenesis, the creation of new blood vessels, and regulate the proliferation and differentiation of placental cells, among other essential functions.
Unlock Peak Performance – Get Your Sample Now:
Key Market Drivers:
- Rising Pregnancy-Related Disorders:The escalating prevalence of pregnancy-related disorders, such as preeclampsia, gestational diabetes, intrauterine growth restriction (IUGR), and placental insufficiency, underscores the need for effective diagnostic tools and therapeutic interventions.
- Enhancing Prenatal Care:Early detection and risk assessment are gaining paramount importance in prenatal care. Placental growth factors like placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) serve as critical biomarkers in assessing the likelihood of pregnancy complications.
- Heightened Awareness:Increasing awareness among healthcare professionals, patients, and advocacy groups regarding the pivotal role of placental health in influencing pregnancy outcomes is propelling the demand for placental growth factors.
As the demand for effective interventions and diagnostics related to placental growth factors continues to rise, the market is at the forefront of advancing maternal and fetal health. Placental growth factors have emerged as indispensable tools in ensuring the well-being of both mother and child during pregnancy.
The future of maternal healthcare is poised for transformation, with Placental Growth Factors playing a vital role in enhancing the health and outcomes of pregnancies worldwide.
Key Players in the Placental Growth Factors Industry
- Alteogen Inc.
- Chengdu Kanghong Pharmaceuticals Group Co Ltd
- Clearside BioMedical, Inc.
- Formycon AG
- Regeneron Pharmaceuticals Inc
- ThromboGenics NV
- Luye Pharma Group Ltd
- Alvotech SA
- Amgen Inc
- Celltrion Inc
- Cinnagen Co
- GlycoNex Inc
Key Developments in the Placental Growth Factors Market:
In March 2023, The suprachoroidal space (SCS®) is being revolutionised by Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical firm. Its results for the fourth quarter and year ending December 31, 2022, were released along with a corporate update.
Segmentation Analysis of the Placental Growth Factors Market
By Therapy Areas:
- Metabolic Disorder
By End User:
- Pharmaceutical and Biotechnology Companies
- Research Centers & Academic Institutes
- CMO and CDMO
- North America
- Latin America
- East Asia
- South Asia
- The Middle East & Africa